乳腺癌衍生的外体miR-92a-3p通过驱动TLR4/NF-κB介导的巨细胞M2极化来刺激恶性进展
Sheng Ding1, Jian Wang1, Jing Pei2
1Department of Thyroid and Breast Surgery, Ma'anshan People's Hospital, Ma'anshan City, Anhui Province, 243000, China.
Biochemical and biophysical research communications
|December 13, 2025
概括
乳腺癌外基因组含有miR-92a-3p,通过通过TLR4/NF-κB通路增加癌细胞入侵和M2巨细胞极化来促进瘤生长. 准这种miRNA为乳腺癌提供了潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 乳腺癌 (BC) 的进展受到外生体的影响,但具体的机制尚未完全理解.
- 外体细胞调解瘤微环境中的通信,影响癌细胞的行为和免疫反应.
研究的目的:
- 为了研究外体微RNA-92a-3p (miR-92a-3p) 在乳腺癌进展中的作用.
- 阐明外体 miR-92a-3p 影响乳腺癌细胞和巨细胞的机制.
主要方法:
- 通过传输电子显微镜 (TEM),纳米粒子跟踪分析 (NTA) 和西式涂抹,对外体进行了分析.
- 使用qRT-PCR量化了微RNA的表达,生物信息学分析确定了miR-92a-3p.
- 评估了巨细胞极化和信号通路 (TLR4 / NF-κB),并且 luciferase 记者测定证实了直接向.
主要成果:
- 瘤衍生的外体细胞增强了BC细胞恶性瘤,这种效应被外体细胞细胞减少了miR-92a-3p.
- 外体miR-92a-3p促进了M2巨细胞的两极分化,并激活了巨细胞中的TLR4/NF-κB通路.
- 证实了miR-92a-3p直接针对TLR4.4的3'UTR.
结论:
- 来自瘤的外体miR-92a-3p通过增强癌细胞的侵入性和诱导M2巨细胞两极化来促进乳腺癌的进展.
- 这种TLR4/NF-κB信号通路是外体miR-92a-3p对巨细胞影响的关键媒介.
- 外体miR-92a-3p代表了乳腺癌治疗的潜在治疗标.
相关概念视频
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K


